Actieve functies van Hilary Webber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Voorzitter | - | - |
Loopbaan van Hilary Webber
Eerdere bekende functies van Hilary Webber
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CANNASOUTH LIMITED | Directeur/Bestuurslid | - | 01-01-2024 |
| Independent Dir/Board Member | - | 01-01-2024 |
Statistieken
Internationaal
| Nieuw-Zeeland | 3 |
Operationeel
| Chairman | 1 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Beurs
- Insiders
- Hilary Webber
- Ervaring
